Table of Contents Table of Contents
Previous Page  1620 / 1726 Next Page
Information
Show Menu
Previous Page 1620 / 1726 Next Page
Page Background

RetroEMBRACE: Late toxicity recorded in 610/731

patients.

Actuarial rates of severe (G3-G5) at 5 years were:

•Bladder 5%

•GI-tract 7%

•Vagina 5%

Monocentric series MRI guided IGABT >100 patients

(Vienna, Aarhus, Paris) report: 5.6% - 7% severe (G3-G5)

morbidity

Sturdza et al. R&O 2016; Potter R&O 2011; Lindegaard Acta Onc 2013; Castelnau-Marchand Gyn Onc 2015

Reported severe morbidity IGABT